Prostate Cancer Radiotherapy Outcomes Worse in Smokers
Patients who smoke during external beam radiotherapy (EBRT) are at increased risk of distant metastases and dying from prostate cancer.
Patients who smoke during external beam radiotherapy (EBRT) are at increased risk of distant metastases and dying from prostate cancer.
Fracture risk after urolithiasis highest among males aged 10 to 19 years and females aged 30 to 39 years.
Significant association observed for high-risk prostate cancers with no difference according to daily dose.
Providers should be embracing this patient engagement tool as much as possible, experts say.